Skip to content

Research paper

Cysteine, cystine or N-acetylcysteine supplementation in parenterally fed neonates.

The Cochrane database of systematic reviews
Q1
Oct 2006
Citations: 105
Influential: 2
Systematic Reviews / Meta-Analyses
90

Study answer

What this study found

Routine cysteine supplementation of cysteine-free PN improved nitrogen balance and plasma cysteine measures, but it did not clearly improve growth. In Zlotkin 1981, weight gain was MD -4.1 g/kg/day (95% CI -9.7 to 1.5), length gain was MD 0 cm/6 days, and nitrogen retention increased WMD 31.8 mg/kg/day (95% CI 8.2 to 55.4). The large extremely low birth weight N-acetylcysteine trial did not show clinical benefit: first-week weight gain MD 0.25 g/kg/day, death by 36 weeks RR 1.23, and no reduction in ROP, NEC, IVH, or PVL; plasma cysteine at end of therapy was slightly lower with…

Study & population
Systematic review and meta-analysis of randomized trials in neonates receiving parenteral nutrition, predominantly preterm, very low birth weight, or extremely low birth weight infants.
Intervention
Randomized trials evaluated short-term parenteral supplementation of neonatal PN with cysteine or cystine, most commonly as cysteine hydrochloride at about 0.46 to 1.0 mmol/kg/day for 6 days or similar brief courses.
Key limitation
Most contributing trials were small and short in duration, with heterogeneous formulations, doses, and comparators.
View sourceOpen PDF

Original abstract

BACKGROUND L-cysteine is thought to be a conditionally essential (i.e., essential under certain conditions) amino acid for neonates. It is a precursor of glutathione, an antioxidant that may reduce oxidation injury. The addition of cysteine to parent…